Thursday, October 29, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

fda concerns unapproved glp-1 drugs retatrutide weight loss

DO

By Daniel Okafor · Regulatory Correspondent

Oct 26 05:32 ETSource: EMY

From the source

fda concerns unapproved glp-1 drugs retatrutide weight loss

Source URL https://emy.gr/body-care-guide/ms-MY/fda-concerns-unapproved-glp-1-drugs-retatrutide-weight-loss

Prescribed peptides from $99/moSee all →